风湿科与呼吸科医生对类风湿关节炎相关间质性肺病的态度与实践:一项国际调查
该国际电子调查共收到616份回复(354名风湿科医生、262名呼吸科医生),来自六大洲。调查发现两类医生在RA-ILD的估计患病率、死亡率、危险因素及有效或应避免的药物方面存在显著差异;风湿科医生对高危无症状患者进行ILD评估的可能性远低于有症状或体征提示ILD的高危患者。研究提示需加强教育以优化RA-ILD的风险评估、筛查和治疗决策。
要点
- 风湿科与呼吸科医生对RA-ILD的患病率、死亡率、危险因素及药物看法存在显著差异。
- 风湿科医生对高危无症状患者评估ILD的可能性远低于有症状或体征提示ILD的高危患者。
- 需加强教育以优化RA-ILD的风险评估、筛查和治疗决策。
核心结论
- 研究揭示了照护RA-ILD患者的医生在疾病评估和临床实践上存在差异,提示需要更多教育以优化风险评估、筛查和治疗决策。
研究设计与样本
- 采用基于Redcap的国际电子调查,分别面向风湿科医生和呼吸科医生,收集RA-ILD的流行病学、检查和管理问题,以及针对风湿科医生的病例情景ILD筛查问题,并收集参与者执业环境、执业年限和国家等人口学数据。
主要发现
- 共收到来自六大洲的616份回复,其中风湿科医生354名、呼吸科医生262名。
- 呼吸科医生与风湿科医生在RA-ILD估计患病率和死亡率、RA发展为ILD的危险因素以及有效或应避免的药物方面回答存在显著差异。
- 风湿科医生对高危无症状患者考虑ILD评估的可能性远低于有症状或体征提示ILD的高危患者。
临床怎么用
- 风湿科医生在RA患者整体健康和肺健康中起核心作用,应关注高危无症状患者的ILD评估。
- 针对RA-ILD的适当筛查和治疗策略研究对风湿科医生有价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study sought to determine the level of understanding and opinion among rheumatologist and pulmonologists regarding risk factors, diagnostic approach and treatment of RA-associated interstitial lung disease (RA-ILD). METHODS: We conducted an international electronic survey of rheumatologists and pulmonologists utilizing two separate Redcap-based surveys with questions on the epidemiology, workup and management of RA-ILD as well as ILD screening questions using case-based scenarios directed at rheumatologists. The survey also collected demographic data on participants including their practice setting, years in practice and country of practice. RESULTS: We received a total of 616 responses (354 rheumatologists and 262 pulmonologists) from six continents. There were significant differences in responses between pulmonologists and rheumatologists in estimated prevalence and mortality, risk factors for the development of ILD in RA and medications that are effective or should be avoided. Rheumatologists were much less likely to consider assessment for ILD in high risk, asymptomatic patients compared with high-risk patients with either symptoms or exam findings suggestive of ILD. CONCLUSION: Our study brought to light the variability in disease assessment and clinical practice among providers caring for patients with RA-ILD and indicate that greater education is needed to optimize clinical decision making in the risk assessment, screening and treatment of RA-ILD. Research questions that address appropriate screening and treatment strategies for RA-ILD will be valuable for rheumatologists given their central role in the overall health and lung health of patients with RA.
引用
- Solomon JJ, Swigris JJ, Kreuter M, et al. The attitudes and practices of physicians caring for patients with rheumatoid arthritis-associated interstitial lung disease: an international survey. Rheumatology (Oxford). 2022. PMID: 34260687. doi:10.1093/rheumatology/keab552
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。